指南与共识妇科

ACOG 委员会意见第 770 号:疑似子宫肌瘤的子宫粉碎术

ACOG Committee Opinion No. 770: Uterine Morcellation for Presumed Leiomyomas.
指南 / 共识 · Obstet Gynecol · 2019-01-01

本委员会意见讨论疑似子宫肌瘤手术中使用粉碎术的问题,指出开放(非封闭)粉碎可能播散未被怀疑的平滑肌肉瘤,术前无法可靠诊断平滑肌肉瘤。妇产科医生应与患者共同决策,知情同意须说明各手术方式及粉碎术的风险与获益和替代方案。

要点

  • 开放(非封闭)粉碎可能播散未被怀疑的平滑肌肉瘤,导致预后可能恶化。
  • 粉碎恶性肿瘤为禁忌,术前应评估以识别恶性肿瘤,但平滑肌肉瘤无法术前可靠诊断。
  • 腹式子宫切除术或肌瘤切除术可能降低未诊断平滑肌肉瘤播散风险,但较微创方式并发症增加。

核心结论

  • 粉碎术是缩小子宫或肌瘤以便经小切口或腹腔镜器械取出组织的手术技术。
  • 开放(非封闭)粉碎子宫和肌瘤因可能播散未被怀疑的平滑肌肉瘤而受到审视。
  • 粉碎恶性肿瘤为禁忌,术前应评估以识别恶性肿瘤,但平滑肌肉瘤无法术前可靠诊断。
  • 腹式子宫切除术或肌瘤切除术可能降低未诊断平滑肌肉瘤患者播散癌细胞的机会,但较微创方式并发症增加。
  • 妇产科医生与患者应共同决策,知情同意须说明各手术方式及粉碎术的风险、获益与替代方案。

研究设计与样本

  • 美国妇产科医师学会(ACOG)委员会意见。

主要发现

  • 开放(非封闭)粉碎子宫和肌瘤可能播散未被怀疑的平滑肌肉瘤。
  • 平滑肌肉瘤无法术前可靠诊断,疑似肌瘤患者可能携带恶性肿瘤并经粉碎播散,导致预后可能恶化。
  • 腹式子宫切除术或肌瘤切除术可能降低未诊断平滑肌肉瘤播散癌细胞的机会,但较微创方式并发症增加。

关键数值与推荐

  • 粉碎恶性肿瘤为禁忌。
  • 术前应评估以识别恶性肿瘤。
  • 妇产科医生与患者应共同决策,知情同意须说明各手术方式及粉碎术的风险、获益与替代方案。

临床怎么用

  • 妇产科医生与患者应共同决策,知情同意须说明各手术方式及粉碎术的风险、获益与替代方案。

局限性

  • 平滑肌肉瘤无法术前可靠诊断。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Morcellation is a surgical technique used to reduce the size of the uterus or myomas by creating smaller pieces to allow the tissue to be removed through small incisions or with laparoscopic instruments. Open (uncontained) morcellation of the uterus and myomas has been scrutinized because of the possible spread of an unsuspected leiomyosarcoma while using a power morcellator during a hysterectomy or myomectomy for presumed symptomatic uterine leiomyomas. Before considering open morcellation of the uterus, a woman should be evaluated to determine if she is at increased risk of malignancy of the uterine corpus. Morcellation of a malignancy is contraindicated, and women should be evaluated preoperatively to identify malignancy. However, leiomyosarcoma cannot be reliably diagnosed preoperatively; thus, there is a risk that a woman with a presumed leiomyoma may have a malignancy that may be spread through morcellation, leading to a potentially worsened prognosis. Although an abdominal hysterectomy or myomectomy may reduce the chance of spreading cancer cells in women with undiagnosed leiomyosarcoma, it is associated with increased morbidity when compared with minimally invasive approaches. The obstetrician-gynecologist and patient should engage in shared decision making, including informed consent explaining the risks and benefits of each approach to surgery for presumed leiomyomas, the risks and benefits of morcellation, and alternatives to morcellation.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. ACOG Committee Opinion No. 770: Uterine Morcellation for Presumed Leiomyomas. Obstet Gynecol. 2019. PMID: 30801477. doi:10.1097/AOG.0000000000003126

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。